{
    "Rank": 198,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT03556566",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "V3-OVA-01"
                },
                "Organization": {
                    "OrgFullName": "Immunitor LLC",
                    "OrgClass": "INDUSTRY"
                },
                "BriefTitle": "Open Label Immunotherapy Trial for Ovarian Cancer",
                "OfficialTitle": "Open Label, One-arm, 3-month Study of Once-daily Tablet of V3-OVA as Immunotherapy of Ovarian Cancer",
                "Acronym": "V3-OVA"
            },
            "StatusModule": {
                "StatusVerifiedDate": "August 2019",
                "OverallStatus": "Unknown status",
                "LastKnownStatus": "Recruiting",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "July 1, 2018",
                    "StartDateType": "Actual"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "November 30, 2019",
                    "PrimaryCompletionDateType": "Anticipated"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "December 31, 2019",
                    "CompletionDateType": "Anticipated"
                },
                "StudyFirstSubmitDate": "May 26, 2018",
                "StudyFirstSubmitQCDate": "June 13, 2018",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "June 14, 2018",
                    "StudyFirstPostDateType": "Actual"
                },
                "LastUpdateSubmitDate": "August 29, 2019",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "August 30, 2019",
                    "LastUpdatePostDateType": "Actual"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyType": "Sponsor"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "Immunitor LLC",
                    "LeadSponsorClass": "INDUSTRY"
                }
            },
            "OversightModule": {
                "OversightHasDMC": "No",
                "IsFDARegulatedDrug": "No",
                "IsFDARegulatedDevice": "No"
            },
            "DescriptionModule": {
                "BriefSummary": "This Phase II will evaluate a new type of ovarian cancer immunotherapy based on a fundamentally new approach that has been successfully tested in a published clinical study of liver cancer. We will test new tableted preparation, V3-OVA, obtained from hydrolyzed, inactivated blood and tumors of patients with cancer of ovaries. Study will last 3 months, 20 patients will be recruited, given one pill per day for three months. The primary clinical endpoint is effect on tumor size and burden after 3 months. Secondary endpoint will be effect on levels of tumor markers on monthly basis compared to baseline.",
                "DetailedDescription": "Ovarian cancer (OC) - a malignant disease affecting the ovarian tissue - is the sixth most diagnosed cancer among women and causes more deaths than any other cancer of the female reproductive system. For treatment of OC, surgical intervention, chemotherapy, as well as radiation methods are used. Despite treatment, about 70% of patients have a relapse. Many different types of immunotherapy (especially checkpoint inhibitors) of OC being tested, but so far the successes have been insignificant, and serious side effects are frequent and unpredictable. This Phase II will evaluate a new type of ovarian cancer immunotherapy based on a fundamentally new approach that has been successfully tested in a published clinical study of liver cancer. We will test new tableted preparation, V3-OVA, obtained from hydrolyzed, inactivated blood and tumor tissues of patients with cancer of ovaries. Study will last 3 months, 20 patients will be recruited, given one pill per day for three months. The primary clinical endpoint is effect on tumor size and burden after 3 months. Secondary endpoint will be effect on levels of tumor markers on monthly basis compared to baseline."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Ovarian Cancer"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "ovary",
                        "ovarian",
                        "immunotherapy",
                        "cancer"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Interventional",
                "PhaseList": {
                    "Phase": [
                        "Phase 2"
                    ]
                },
                "DesignInfo": {
                    "DesignAllocation": "N/A",
                    "DesignInterventionModel": "Single Group Assignment",
                    "DesignInterventionModelDescription": "Single arm, open label Phase II study in volunteers with ovarian cancer receiving daily dose of one pill of vaccine V3-OVA",
                    "DesignPrimaryPurpose": "Treatment",
                    "DesignMaskingInfo": {
                        "DesignMasking": "None (Open Label)",
                        "DesignMaskingDescription": "no masking"
                    }
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "20",
                    "EnrollmentType": "Anticipated"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "V3-OVA treatment arm",
                            "ArmGroupType": "Experimental",
                            "ArmGroupDescription": "Oral once daily pill of tableted vaccine (V3-OVA) containing ovarian cancer antigens administered for 3 months in 20 volunteers with ovarian cancer",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Biological: Tableted vaccine (V3-OVA) containing ovarian cancer antigens"
                                ]
                            }
                        }
                    ]
                },
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Biological",
                            "InterventionName": "Tableted vaccine (V3-OVA) containing ovarian cancer antigens",
                            "InterventionDescription": "One pill of V3-OVA per day for three months",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "V3-OVA treatment arm"
                                ]
                            },
                            "InterventionOtherNameList": {
                                "InterventionOtherName": [
                                    "V3-OVA"
                                ]
                            }
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Changes in tumor size and burden compared to baseline",
                            "PrimaryOutcomeDescription": "Intravaginal ultrasonography to measure changes in tumor size and burden",
                            "PrimaryOutcomeTimeFrame": "Monthly for 3 months"
                        }
                    ]
                },
                "SecondaryOutcomeList": {
                    "SecondaryOutcome": [
                        {
                            "SecondaryOutcomeMeasure": "Effect on level of serum tumor markers compared to baseline",
                            "SecondaryOutcomeDescription": "Commonly measured tumor markers associated with ovarian cancer, primarily CA125, at baseline and at study termination",
                            "SecondaryOutcomeTimeFrame": "Monthly for three months"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "Inclusion Criteria:\n\nConfirmed diagnosis of ovarian cancer Positive for CA125 tumor marker at above normal threshold level -\n\nExclusion Criteria:\n\nMetastases to other sites\n\n-",
                "HealthyVolunteers": "No",
                "Gender": "Female",
                "GenderBased": "Yes",
                "GenderDescription": "Ovarian cancer is female gynecological cancer",
                "MinimumAge": "18 Years",
                "MaximumAge": "65 Years",
                "StdAgeList": {
                    "StdAge": [
                        "Adult",
                        "Older Adult"
                    ]
                }
            },
            "ContactsLocationsModule": {
                "CentralContactList": {
                    "CentralContact": [
                        {
                            "CentralContactName": "Galyna Kutsyna, MD, MD/PhD",
                            "CentralContactRole": "Contact",
                            "CentralContactPhone": "+97695130306",
                            "CentralContactEMail": "kutsynagalyna@yahoo.com"
                        },
                        {
                            "CentralContactName": "Marina Tarakanovskaya, MD",
                            "CentralContactRole": "Contact",
                            "CentralContactPhone": "+97695130306",
                            "CentralContactEMail": "marinatarakanovskaya@yahoo.com"
                        }
                    ]
                },
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "Aldar Bourinbaiar, PhD, MD/PhD",
                            "OverallOfficialAffiliation": "Immunitor LLC",
                            "OverallOfficialRole": "Study Chair"
                        }
                    ]
                },
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "Immunitor LLC",
                            "LocationStatus": "Recruiting",
                            "LocationCity": "Ulaanbaatar",
                            "LocationCountry": "Mongolia",
                            "LocationContactList": {
                                "LocationContact": [
                                    {
                                        "LocationContactName": "Aldar Bourinbaiar, MD",
                                        "LocationContactRole": "Contact",
                                        "LocationContactPhone": "97695130306",
                                        "LocationContactEMail": "aldar@immunitor.com"
                                    },
                                    {
                                        "LocationContactName": "Marina Tarakanovskaya, MD",
                                        "LocationContactRole": "Contact",
                                        "LocationContactEMail": "marinatarakanovskaya@yahoo.com"
                                    },
                                    {
                                        "LocationContactName": "Galyna Kutsyna, MD",
                                        "LocationContactRole": "Principal Investigator"
                                    }
                                ]
                            }
                        }
                    ]
                }
            },
            "IPDSharingStatementModule": {
                "IPDSharing": "No",
                "IPDSharingDescription": "Data will be shared upon study completion in peer-reviewed publication"
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000010051",
                            "ConditionMeshTerm": "Ovarian Neoplasms"
                        },
                        {
                            "ConditionMeshId": "D000077216",
                            "ConditionMeshTerm": "Carcinoma, Ovarian Epithelial"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000004701",
                            "ConditionAncestorTerm": "Endocrine Gland Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000009371",
                            "ConditionAncestorTerm": "Neoplasms by Site"
                        },
                        {
                            "ConditionAncestorId": "D000009369",
                            "ConditionAncestorTerm": "Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000010049",
                            "ConditionAncestorTerm": "Ovarian Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000000291",
                            "ConditionAncestorTerm": "Adnexal Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000005831",
                            "ConditionAncestorTerm": "Genital Diseases, Female"
                        },
                        {
                            "ConditionAncestorId": "D000052776",
                            "ConditionAncestorTerm": "Female Urogenital Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000005261",
                            "ConditionAncestorTerm": "Female Urogenital Diseases and Pregnancy Complications"
                        },
                        {
                            "ConditionAncestorId": "D000091642",
                            "ConditionAncestorTerm": "Urogenital Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000005833",
                            "ConditionAncestorTerm": "Genital Neoplasms, Female"
                        },
                        {
                            "ConditionAncestorId": "D000014565",
                            "ConditionAncestorTerm": "Urogenital Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000091662",
                            "ConditionAncestorTerm": "Genital Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000004700",
                            "ConditionAncestorTerm": "Endocrine System Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000006058",
                            "ConditionAncestorTerm": "Gonadal Disorders"
                        },
                        {
                            "ConditionAncestorId": "D000002277",
                            "ConditionAncestorTerm": "Carcinoma"
                        },
                        {
                            "ConditionAncestorId": "D000009375",
                            "ConditionAncestorTerm": "Neoplasms, Glandular and Epithelial"
                        },
                        {
                            "ConditionAncestorId": "D000009370",
                            "ConditionAncestorTerm": "Neoplasms by Histologic Type"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M12664",
                            "ConditionBrowseLeafName": "Ovarian Neoplasms",
                            "ConditionBrowseLeafAsFound": "Ovarian Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M1704",
                            "ConditionBrowseLeafName": "Carcinoma, Ovarian Epithelial",
                            "ConditionBrowseLeafAsFound": "Ovarian Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M5224",
                            "ConditionBrowseLeafName": "Carcinoma",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M7553",
                            "ConditionBrowseLeafName": "Endocrine Gland Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M12662",
                            "ConditionBrowseLeafName": "Ovarian Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M3333",
                            "ConditionBrowseLeafName": "Adnexal Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8633",
                            "ConditionBrowseLeafName": "Genital Diseases, Female",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M2877",
                            "ConditionBrowseLeafName": "Genital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M2876",
                            "ConditionBrowseLeafName": "Urogenital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M26783",
                            "ConditionBrowseLeafName": "Female Urogenital Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M13817",
                            "ConditionBrowseLeafName": "Pregnancy Complications",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8089",
                            "ConditionBrowseLeafName": "Female Urogenital Diseases and Pregnancy Complications",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8635",
                            "ConditionBrowseLeafName": "Genital Neoplasms, Female",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M17005",
                            "ConditionBrowseLeafName": "Urogenital Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M7552",
                            "ConditionBrowseLeafName": "Endocrine System Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8853",
                            "ConditionBrowseLeafName": "Gonadal Disorders",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M12010",
                            "ConditionBrowseLeafName": "Neoplasms, Glandular and Epithelial",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M12005",
                            "ConditionBrowseLeafName": "Neoplasms by Histologic Type",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "T4352",
                            "ConditionBrowseLeafName": "Ovarian Cancer",
                            "ConditionBrowseLeafAsFound": "Ovarian Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "T4354",
                            "ConditionBrowseLeafName": "Ovarian Epithelial Cancer",
                            "ConditionBrowseLeafAsFound": "Ovarian Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC04",
                            "ConditionBrowseBranchName": "Neoplasms"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BXS",
                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC19",
                            "ConditionBrowseBranchName": "Gland and Hormone Related Diseases"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "Rare",
                            "ConditionBrowseBranchName": "Rare Diseases"
                        }
                    ]
                }
            },
            "InterventionBrowseModule": {
                "InterventionBrowseLeafList": {
                    "InterventionBrowseLeaf": [
                        {
                            "InterventionBrowseLeafId": "M17050",
                            "InterventionBrowseLeafName": "Vaccines",
                            "InterventionBrowseLeafRelevance": "low"
                        },
                        {
                            "InterventionBrowseLeafId": "M2854",
                            "InterventionBrowseLeafName": "Immunomodulating Agents",
                            "InterventionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "InterventionBrowseBranchList": {
                    "InterventionBrowseBranch": [
                        {
                            "InterventionBrowseBranchAbbrev": "All",
                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                        }
                    ]
                }
            }
        }
    }
}